This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Andreas Kuhn, PhD
Vice President, RNA Biochemistry & Manufacturing at BioNTech RNA Pharmaceuticals GmbH
Speaker

Agenda Sessions

  • Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2”

    On Demand - Premium Only
    View Session

At this event

Prev
Next
Robert Langer, PhD, Sc.D.
David H. Koch Institute Professor, Koch Institute of Integrative Cancer Research
Massachusetts Institute of Technology

See Andreas at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub